Doctor on Social Media: Educational Content vs. Covert Advertising – Legal Boundaries and Risks

Social media has become an essential channel for physicians to share knowledge, correct misinformation, and engage with patients. Yet the line between educational content and covert advertising is dangerously thin. Across jurisdictions, regulators have responded with a wave of new rules: Turkey’s 2025 Regulation on Promotion and Information Activities in Healthcare Services introduced strict prohibitions on before‑after photos, treatment guarantees, and demand‑generating content; the American Medical Association (AMA) published a landmark deepfake and AI‑impersonation framework in April 2026; the UK General Medical Council (GMC) updated its standalone social‑media guidance in 2024; France’s National Council of Physicians (CNOM) issued a first‑of‑its‑kind charter for physician content creators in January 2025; Poland amended its Code of Medical Ethics to permit—but tightly regulate—physician advertising on social media; and Germany’s Higher Regional Court of Cologne (OLG Köln) established joint liability for pharmaceutical companies and physician‑influencers in September 2025. Enforcement is real: state medical boards in the United States, the GMC’s Medical Practitioners Tribunal Service (MPTS) in the United Kingdom, and Turkey’s Provincial Evaluation Commissions have all imposed sanctions—ranging from fines to license revocation—for social‑media misconduct. This article provides a deep, multi‑jurisdictional analysis of the legal and ethical boundaries governing physician‑generated content, drawing on primary regulatory sources and official guidance from medical oversight bodies across North America, Europe, and Asia‑Pacific.

This article is part of a strategic content series powered by LOREX – an IP development model for experts.

1. The Foundational Prohibition: Why Physicians Cannot Advertise Like Businesses

Unlike commercial enterprises, the medical profession is built on public service, trust, and patient welfare. Every major medical‑ethics code derives from the principle that the patient’s interest takes precedence over the physician’s commercial interest. This principle is the source of the advertising restrictions that apply worldwide.

1.1 Turkey: The 2025 Regulation in Context

Turkey’s regulatory framework is among the most restrictive globally. The primary legal instruments include:

• Law No. 1219 on the Practice of Medicine and Medical Sciences – Articles 24 and 40 restrict physician announcements to name, specialty, practice address, and working hours only. Any content exceeding these narrow categories risks classification as prohibited advertising.
• Medical Deontology Regulation (Tıbbi Deontoloji Nizamnamesi) – Article 8 prohibits giving the medical profession a commercial character and bans thank‑you announcements and patient testimonials. Article 26 provides for criminal liability in cases of confidentiality breaches.
• 2025 Regulation on Promotion and Information Activities in Healthcare Services – The most comprehensive digital‑era framework, effective November 2025. (Source: Turkish Dental Association)

The core principle is that medical services cannot be marketed as commodities. Any content that creates demand for a specific physician or clinic—even indirectly—may be classified as prohibited advertising under Article 5 of the 2025 Regulation.

1.2 United States: AMA Code of Medical Ethics Opinion 2.3.2

Opinion 2.3.2, Physicians’ Use of Social Media for Product Promotion and Compensation, states unequivocally that physicians and medical students “cannot realistically separate their personal and professional personas entirely online and should curate their social media presence accordingly.” Key obligations include:

• Maintain appropriate boundaries of the patient–physician relationship in accordance with ethics guidance if interacting with patients through social media.
• Use privacy settings to safeguard personal information and content, but be aware that once on the internet, content is likely there permanently. Routinely monitor one’s social media presence to ensure that personal and professional information published by others is accurate and appropriate.
• Publicly disclose any financial interests related to social media content, including paid partnerships and corporate sponsorships.
• When using social media to disseminate medical or health‑care information, ensure that such information is useful and accurate based on professional medical judgment.

Source: AMA Code of Medical Ethics, Opinion 2.3.2, available at https://code-medical-ethics.ama-assn.org/ethics-opinions/physicians-use-social-media-product-promotion-and-compensation.

The AMA’s position is grounded in fiduciary duty: physicians’ recommendations carry the weight of professional authority, and any undisclosed financial interest in a product or service they promote constitutes a breach of that duty. The Federal Trade Commission (FTC) reinforces this through its Endorsement Guides (updated 2023), which require clear and conspicuous disclosure of material connections—using labels like #ad or #sponsored—in all influencer and expert endorsements. Source: FTC Endorsement Guides.

1.3 United Kingdom: GMC’s Using Social Media as a Medical Professional (2024)

The GMC’s standalone guidance, which came into effect on 30 January 2024 and was updated on 13 December 2024 to include physician associates and anaesthesia associates, makes clear that social‑media communications are subject to the same professional standards as any other public communication.

Key provisions include:

• “You must take reasonable steps to make sure that the information you communicate on social media as a medical professional is not false or misleading and does not exploit people’s vulnerability or lack of medical knowledge. You must not misrepresent your experience and qualifications.”
• “If you use social media to advertise your services, or use your professional position to promote or endorse any other services or products, you must be open and honest about any interests you have that may influence (or could be seen to influence) the recommendations you make.”
• When commenting on health or healthcare issues, medical professionals “should usually say who you are”—anonymity does not shield physicians from accountability.
• Physicians are advised not to “friend” or establish personal social‑media connections with current patients, as doing so blurs professional boundaries.

Source: GMC, Using Social Media as a Medical Professional, available at https://www.gmc-uk.org/professional-standards/the-professional-standards/using-social-media-as-a-medical-professional.

Explore the core problem LOREX solves →

2. What Is Permitted? Educational Content Across Jurisdictions

Drawing together the Turkish, AMA, GMC, and European frameworks, a clear taxonomy emerges distinguishing permissible educational content from prohibited promotion.

2.1 Turkey: The 2025 Regulation’s Information–Promotion Distinction

The 2025 Regulation distinguishes between information (permitted) and promotion (prohibited). Educational content is allowed if it meets strict criteria:

• It is based on scientific evidence and peer‑reviewed knowledge.
• It does not create demand for a specific healthcare provider.
• It includes a mandatory disclaimer: “This content is for informational purposes only. Please consult your physician for diagnosis and treatment.”
• It does not contain pricing information, discounts, or campaigns.
• It does not use superlatives such as “best,” “most successful,” or “100% guaranteed.”

For example, a cardiologist may post a video explaining hypertension risk factors. That is education. The same cardiologist posting “I treat hypertension better than anyone in Istanbul” is advertising—and subject to discipline.

2.2 United Kingdom: Public‑Interest Justification

The GMC acknowledges that social media can be used “to benefit patient care, education and learning.” This public‑interest rationale permits physicians to share evidence‑based health information, correct misinformation, and participate in public discourse—provided the content meets the honesty and transparency standards set out in the guidance. The key safeguard is that the physician must identify himself or herself by name and qualification, enabling the audience to assess the credibility of the information.

2.3 France: The CNOM Charter for Physician Content Creators (2025)

In January 2025, the Conseil National de l’Ordre des Médecins (CNOM) published a 10‑principle Charte du médecin créateur de contenu responsable (Charter for the Responsible Physician Content Creator). The charter was developed in consultation with physician content creators and platform experts and represents one of the most forward‑looking regulatory instruments in Europe. It requires that physician‑created content:

• Be scientifically rigorous and accessible.
• Be clearly identified as coming from a qualified medical professional.
• Not present unverified hypotheses as established fact.
• Respect all ethical obligations—including professional confidentiality, dignity, and collegiality—applicable to any other form of medical communication.
• Refrain from promoting unproven or non‑conventional practices.

Source: CNOM, Une charte du médecin créateur de contenu responsable, 10 January 2025, available at https://www.conseil-national.medecin.fr/publications/actualites/charte-medecin-createur-contenu-responsable.

The CNOM Charter does not relax the advertising prohibition; it makes it operational in the digital environment, acknowledging that physician‑generated social‑media content can be a public good—provided it meets the same ethical standards as traditional medical publishing.

2.4 Poland: The 2025 Amendment to the Code of Medical Ethics (KEL)

Poland has taken one of the most significant liberalizing steps in Europe. Effective 1 January 2025, an amended Kodeks Etyki Lekarskiej (KEL)—adopted by the Extraordinary XVI National Congress of Physicians in May 2024—introduces, for the first time, direct provisions on physicians’ use of social media. The Naczelna Izba Lekarska (NIL), Poland’s supreme medical chamber, stated that the most important changes “concern social media in the medical profession—they constitute the essence of ethics and responsibility of physicians in using online platforms.”

The amended KEL explicitly permits physicians and dentists to advertise their services on social media. However, the permission is not unlimited:

• Advertising must be transparent and honest.
• A physician must not use his or her professional authority to promote products or services that are unrelated to the practice of medicine.
• The physician’s public communication must not violate the core ethical values of the profession, including patient dignity and professional integrity.

Source: NIL, Nowy KEL od 1 stycznia 2025, available at https://nil.org.pl/drukuj/8721/1.

Poland’s approach represents a controlled opening: the physician is allowed to inform the public about his or her services, but the informational function must not be conflated with commercial exploitation of the physician’s professional standing.

Learn more about the LOREX model for compliant expert content →

3. Strictly Prohibited Practices: A Comparative Table

The following practices are explicitly or presumptively banned across the surveyed jurisdictions:

Violations trigger a multi‑stage enforcement process in Turkey: first, a warning and content removal request; second, administrative fines (doubling for repeat offenses); third, referral to the medical chamber for professional discipline, which can include temporary or permanent license suspension. Equivalent escalation mechanisms exist in the UK (GMC investigation → MPTS tribunal → erasure from the register), the United States (state medical board investigation → license suspension or revocation), and Australia (Medical Board referral → disciplinary tribunal).

4. The Special Case of Before‑After Photos and AI‑Generated Images

Before‑after photos occupy a particularly sensitive position across all surveyed jurisdictions. Both the CNOM Charter and the GMC’s boundary guidance indicate that even when a patient consents, such images are inherently promotional: they selectively present favorable outcomes and create expectations that cannot be guaranteed for every patient.

4.1 Turkey: Presumptive Advertising

Under the 2025 Regulation, before‑after photos are treated as presumptive advertising and are banned in most contexts, even with patient consent. If a physician wishes to use such images for genuine educational purposes (e.g., academic presentation), strict rules apply:

• Written consent must be obtained using a specific “Visual Content Consent Form” (Annex‑1), different from general treatment consent. (Source: TDB)
• No financial incentive or discount may be given in exchange for consent.
• No filters, Photoshop, or misleading lighting are allowed—images must be raw and authentic.
• The date of the procedure and the date of the photo must be clearly stated.
• Comments must be disabled on any social media post containing clinical images.

4.2 United States: The AMA’s 2026 Deepfake Framework

The AMA’s 2026 policy framework on AI‑generated deepfakes, announced in April 2026, represents the most comprehensive regulatory response globally to the intersection of AI and physician identity. Built on seven key principles, the framework establishes:

1. Physician Identity Is a Protected Right—a physician’s name, image, likeness, voice, and digital replicas are protected and may only be used with affirmative, informed consent.
2. Prohibition on Deceptive Medical Impersonation—any AI‑generated or altered content impersonating a physician, especially if it falsely conveys endorsement, is prohibited and treated as deception.
3. Informed, Opt‑In, and Revocable Consent—consent must be specific, explicit, and revocable at any time.
4. Mandatory Labeling and Transparency—all AI‑generated or altered depictions must be clearly labeled in plain language and carry a digital watermark.
5. Shared Responsibility—platforms, hospitals, and AI vendors share responsibility for preventing impersonation.
6. Enforcement and Practical Remedies—physicians must have access to takedown mechanisms and remedies.
7. Minimizing Administrative Burden—identity protection should be the default.

Source: AMA, AMA urges physician protections against AI deepfake impersonation, 29 April 2026, available at https://www.ama-assn.org/press-center/ama-press-releases/ama-urges-physician-protections-against-ai-deepfake-impersonation.

The practical implication is clear: a physician who uses AI to generate or alter an image of a patient—even with the patient’s consent—may be in breach of multiple ethical obligations, including the duty of honesty, the duty to maintain professional boundaries, and, if the image is used without proper labeling, the emerging duty of transparency regarding synthetic content.

5. European Developments: France, Germany, and Poland in Depth

5.1 France: The CNOM Charter as a Model for Regulated Participation

The CNOM’s 2025 Charter is significant because it acknowledges and legitimizes the physician content creator while imposing professional‑grade standards. The Charter was adopted after extensive consultation with practicing physician‑influencers, platform representatives, and ethics experts, reflecting a participatory regulatory approach that contrasts with the more prescriptive Turkish model.

Key operational requirements include: (i) content must be identifiable as coming from a physician; (ii) the physician must cite his or her specialty and qualifications; (iii) scientific claims must be sourced to peer‑reviewed evidence; (iv) speculative or hypothetical statements must be clearly labeled as such; and (v) the physician must not use his or her professional authority to endorse commercial products unrelated to medical practice. Source: CNOM Charter.

5.2 Germany: Joint Liability for Physician‑Influencers and Sponsors

On 11 September 2025, the Higher Regional Court of Cologne (Oberlandesgericht Köln, case no. 6 U 118/24) issued a landmark ruling that significantly expanded liability for health‑related advertising on social media. The court held that pharmaceutical companies and paid influencers share joint responsibility for ensuring compliance with the Heilmittelwerbegesetz (HWG, the German Medicines Advertising Act).

Under the ruling, mandatory warning statements required by the HWG must appear in all audiovisual formats, including short‑form social‑media reels. The practical effect is that a physician‑influencer who fails to include the required statutory warnings in a sponsored post can be held jointly liable alongside the sponsoring company. This aligns with a broader European trend: the European Commission is currently evaluating a Digital Fairness Act that would impose further transparency obligations on digital advertising, including in the healthcare sector. Source: OLG Köln, judgment of 11 September 2025, 6 U 118/24.

5.3 Poland: The Controlled Opening

Poland’s 2025 amendment to the KEL represents the most liberal approach in Europe, explicitly permitting physician advertising on social media for the first time. The NIL’s rationale was that physicians needed clear rules for the digital environment rather than a blanket prohibition that was increasingly unenforceable. However, the permission is bounded by the principle that the physician must not commercialize professional authority: endorsing products or services unrelated to medicine remains prohibited, and all advertising must be truthful and transparent. Source: NIL, Nowy KEL.

6. Global Regulatory Comparison: Australia and India

6.1 Australia: The Testimonial Ban

The Medical Board of Australia’s Guidelines for Advertising Regulated Health Services impose one of the strictest testimonial bans in the world. The guidelines prohibit the use of patient testimonials in advertising a regulated health service. While patients are free to share their views on personal social‑media accounts, a practitioner must not reproduce or use those comments in his or her own advertising or professional content. This prohibition applies even if the patient voluntarily provides the testimonial and consents to its use.

Source: Medical Board of Australia, Guidelines for Advertising Regulated Health Services, available at https://www.medicalboard.gov.au/Codes-Guidelines-Policies/Guidelines-for-advertising-regulated-health-services.aspx.

6.2 India: The NMC’s Prohibitive Approach

The National Medical Commission of India has issued regulations under the National Medical Commission Act, 2019, that prohibit registered medical practitioners from soliciting patients through social media, advertising their services, or publishing testimonials. The underlying principle is that any promotional activity that could be construed as canvassing for patients is incompatible with the dignity of the medical profession. Source: National Medical Commission.

7. Patient Privacy: HIPAA, GDPR, KVKK, and Professional Confidentiality

A recurring theme across all jurisdictions is the primacy of patient privacy. The legal frameworks differ in structure but converge in substance.

7.1 United States: HIPAA

The HIPAA Privacy Rule (45 CFR Part 160 and Subparts A and E of Part 164) establishes that protected health information (PHI) may not be disclosed on social media without the patient’s written authorization—except in narrow, specifically defined circumstances. The rule applies to all “covered entities,” including individual physicians in private practice. Penalties for non‑compliance range from civil monetary penalties to criminal prosecution in cases of knowing or fraudulent disclosure. Source: HHS, Summary of the HIPAA Privacy Rule.

7.2 Turkey: KVKK and Confidentiality Obligations

Under Turkey’s KVKK (Law No. 6698 on the Protection of Personal Data), health data is considered special category personal data. Key requirements include:

• Explicit, written, and informed consent must be obtained before any patient image or case discussion is shared.
• Consent must be revocable at any time without justification.
• Even anonymized data may be re‑identifiable—courts have found that pixelated faces or blurred tattoos are insufficient to protect identity.
• Violations can result in administrative fines and criminal prosecution for breach of confidentiality under Article 26 of the Medical Deontology Regulation.

7.3 United Kingdom and Europe: GDPR and GMC Confidentiality

The GMC’s Confidentiality: Good Practice in Handling Patient Information applies with equal force online: “You must not disclose identifiable information about patients, when using social media, unless you have explicit consent to do so—for example, for educational purposes.” Under the GDPR, health data is special‑category data requiring explicit consent for processing, and patients have the right to withdraw consent at any time. Source: GMC Social Media Guidance.

8. Platform‑Specific Policies: Meta, LinkedIn, and Google

Even if a physician’s content complies with the ethical codes of his or her jurisdiction, it must also comply with the terms of service of the platforms on which it appears. The major platforms have introduced health‑specific advertising and content restrictions:

• Meta (Facebook/Instagram): Restricts advertisements that imply negative self‑perception or promote unrealistic body image. Cosmetic procedure advertising faces heightened scrutiny, and before‑after images may be rejected or removed. Source: Meta Ad Standards.
• LinkedIn: Prohibits the use of its Insight Tag for retargeting healthcare advertisements and restricts the promotion of prescription drugs to consumers. Source: LinkedIn Advertising Policies.
• Google: Requires certification for healthcare and medical device advertising in certain regions (e.g., G2 certification) and enforces strict policies against misleading health claims. Source: Google Ads Healthcare and Medicines Policy.

Violating platform policies can result in content removal, account suspension, or permanent de‑platforming—cutting off the physician’s legitimate educational channel alongside any questionable promotional content.

Discover why series logic outperforms one‑off promotional posts →

9. AI‑Generated Content: A New Frontier of Legal and Ethical Risk

The increasing use of generative AI tools (large language models, image generators, and synthetic voice technology) to draft social‑media posts, patient‑education materials, or marketing copy has introduced a new dimension of legal and ethical risk.

9.1 The AMA’s 2026 Deepfake Framework

As outlined in Section 4.2 above, the AMA’s framework addresses the most visible AI risk—impersonation—but the broader issue of AI‑assisted content creation is governed by existing standards: the physician is fully responsible for all published content, whether drafted by a human or generated by a machine. (Source: AMA)

9.2 Hallucinated References and Scientific Integrity

AI models may generate plausible but non‑existent citations, journal articles, or statistics. Publishing such content may constitute professional misconduct, even if the physician did not intend to deceive. The GMC’s requirement that published information be “accurate based on professional medical judgment” places the burden of verification squarely on the physician. “ChatGPT wrote it” is not a defense in any regulatory proceeding. (Source: Kosin Medical Journal)

9.3 Data Privacy and AI Training Risks

Inputting patient data (even partially anonymized) into a public AI tool may violate HIPAA, the GDPR, KVKK, or equivalent local laws, as the data may be stored, processed, or used for model training without the patient’s consent. The AMA recommends that all AI‑assisted patient communication be reviewed by a qualified human clinician before publication. (Source: Mind The Bleep)

10. Sanctions and Real‑World Enforcement

The risk of regulatory action for social‑media violations is not theoretical. Enforcement data from multiple jurisdictions confirms that regulators are actively monitoring and sanctioning physicians for online misconduct.

10.1 Turkey

Turkey’s Provincial Evaluation Commissions actively monitor social media using AI tools. Since the 2025 Regulation took effect, hundreds of physicians have received administrative fines; several private clinics have had their licenses suspended for repeated before‑after photo violations; and in extreme cases, criminal complaints have been filed for practicing medicine outside the scope of law when doctors advertised unapproved treatments. (Source: Oran Partners)

10.2 United States

State medical boards have broad authority to discipline licensees for unprofessional conduct, including social‑media violations. The Medical Board of California, for example, may issue public reprimands, suspend licenses, or revoke licenses for violations of the Medical Practice Act. Ohio Revised Code § 4731.22 authorizes the State Medical Board to limit, revoke, or suspend a license for violations including “failure to maintain minimal standards of care” and “violation of any provision of a code of ethics.” Enforcement actions are published on the relevant Board’s website and remain available indefinitely. (Source: Medical Board of California)

10.3 United Kingdom

The Medical Practitioners Tribunal Service (MPTS), which adjudicates fitness‑to‑practise cases referred by the GMC, has sanctioned doctors for social‑media posts that harassed colleagues, disclosed patient information, or expressed racist views. Sanctions range from warnings and conditions on practice to suspension and erasure from the medical register. (Source: GMC Tribunal)

10.4 Australia

The Medical Board of Australia has referred practitioners to disciplinary tribunals for breaches of the advertising guidelines, including the use of patient testimonials and misleading claims about treatment efficacy. (Source: Medical Board of Australia)

11. Building a Legally Compliant Social Media Presence: A 10‑Principle Framework

Drawing on the regulatory frameworks surveyed, the following principles provide a jurisdiction‑neutral guide for physicians seeking to use social media for professional purposes without violating advertising restrictions or ethical obligations:

1. Educate, do not promote. Each post should be self‑contained as an educational unit: it should answer a genuine medical question or correct a known piece of misinformation. If the primary purpose of a post is to attract patients to your practice, it is likely advertising—and likely prohibited.
2. Identify yourself. State your full name, qualifications, and specialty so that the audience can assess the credibility and limits of the information. The GMC explicitly recommends this; the CNOM Charter requires it.
3. Disclose all conflicts. If a post mentions a product, service, or clinic with which you have a financial relationship, disclose that relationship clearly and conspicuously. The FTC requires #ad or #sponsored labels; the AMA and GMC impose equivalent obligations.
4. Never guarantee outcomes. Medical outcomes are inherently uncertain; any statement that implies a guaranteed result is both misleading and ethically prohibited across all surveyed jurisdictions.
5. Respect patient privacy absolutely. Obtain written consent for any identifiable patient information, and consider whether even anonymized case studies could be re‑identified. HIPAA, GDPR, and KVKK all impose strict liability for breaches.
6. Review AI‑generated content personally. Never publish AI‑generated text, images, or video without a thorough human review for accuracy, bias, and legal compliance. The physician remains the legal and ethical guarantor of all published content.
7. Avoid before‑after images. Even where not explicitly prohibited, these are treated as presumptively promotional by most medical regulators. The educational justification rarely outweighs the risk.
8. Maintain professional boundaries. Do not “friend” current patients or engage in personal social‑media interactions with them. The GMC, AMA, and CNOM all warn against boundary blurring.
9. Monitor your digital footprint. Regularly search for your name and professional profile to identify and address inaccurate, misleading, or unauthorized content posted by third parties. The AMA explicitly recommends routine monitoring.
10. Document compliance. Keep records of patient consents, content review processes, and AI‑usage logs. In the event of a regulatory inquiry, contemporaneous documentation is the best defense.

Get a closer look at the project design phase →

12. The Long‑Term Payoff: Trust Over Attention

Patients are increasingly skeptical of online health information. A physician who consistently produces evidence‑based, educational content—without resorting to advertising tricks—builds genuine trust. That trust translates into patient loyalty, better health outcomes, and professional referrals. Importantly, a compliant educational series becomes a media asset that can be repurposed for years, unlike a single promotional post that may be deleted after a regulatory complaint.

The 2025–2026 regulatory developments surveyed in this article all reflect a common direction of travel: physicians are not prohibited from using social media, but they are held to a higher standard of transparency, accuracy, and professionalism than any other category of content creator. The physician who understands and internalizes this standard—who treats every post as a professional act subject to the same ethical scrutiny as a consultation, a prescription, or a published article—will not only avoid regulatory sanction but will build lasting professional authority in an information environment increasingly polluted by misinformation and commercial exploitation.

Ready to build a medical content series that educates patients without violating advertising rules? The LOREX model provides a structured, legally compliant framework for physicians. Stop risking your license—start building lasting educational authority.

Apply to start your LOREX project today →

---

Frequently Asked Questions (FAQ)

---

This article is part of the LOREX series on compliant healthcare content and IP development. For more insights, visit our blog. Last updated: 14 May 2026.